US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 20.710
  • -0.060-0.29%
Trading Nov 21 13:21 ET
612.95MMarket Cap-9063P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dianthus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 762.000K--
--2024/Q4-- / 844.110K--
--2024/Q32.172M / 576.440K--
--2024/Q21.863M / 322.750K--
--2024/Q1874.000K / 371.400K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 762.000K--
--2024/Q4-- / 844.110K--
--2024/Q32.172M / 576.440K--
--2024/Q21.863M / 322.750K--
--2024/Q1874.000K / 371.400K--

Unlock Free Earnings Estimates

Dianthus Therapeutics Earnings Reports

  • Dianthus Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:10 ET

  • Dianthus Therapeutics | 10-Q: Quarterly report

    Aug 8 16:16 ET

  • Dianthus Therapeutics | 10-Q: Quarterly report

    May 9 16:53 ET

  • Dianthus Therapeutics | 10-K: FY2023 Annual Report

    Mar 21 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 11, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data